HK1179609A1 - 喹嗪烷和吲嗪烷衍生物 - Google Patents
喹嗪烷和吲嗪烷衍生物Info
- Publication number
- HK1179609A1 HK1179609A1 HK13106614.8A HK13106614A HK1179609A1 HK 1179609 A1 HK1179609 A1 HK 1179609A1 HK 13106614 A HK13106614 A HK 13106614A HK 1179609 A1 HK1179609 A1 HK 1179609A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- quinolizidine
- indolizidine
- derivatives
- indolizidine derivatives
- Prior art date
Links
- HAJKHJOABGFIGP-UHFFFAOYSA-N indolizidine Chemical class C1CCCN2CCCC21 HAJKHJOABGFIGP-UHFFFAOYSA-N 0.000 title 1
- LJPZHJUSICYOIX-UHFFFAOYSA-N quinolizidine Chemical compound C1CCCC2CCCCN21 LJPZHJUSICYOIX-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10166776 | 2010-06-22 | ||
PCT/EP2011/060077 WO2011161008A1 (en) | 2010-06-22 | 2011-06-17 | Quinolizidine and indolizidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1179609A1 true HK1179609A1 (zh) | 2013-10-04 |
Family
ID=44314179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13106614.8A HK1179609A1 (zh) | 2010-06-22 | 2013-06-05 | 喹嗪烷和吲嗪烷衍生物 |
Country Status (23)
Country | Link |
---|---|
US (1) | US8143273B2 (zh) |
EP (1) | EP2585460B1 (zh) |
JP (1) | JP5659299B2 (zh) |
KR (1) | KR101431949B1 (zh) |
CN (1) | CN102947301B (zh) |
AR (1) | AR082766A1 (zh) |
AU (1) | AU2011269147A1 (zh) |
BR (1) | BR112012030886A2 (zh) |
CA (1) | CA2797874C (zh) |
CL (1) | CL2012003553A1 (zh) |
CO (1) | CO6630104A2 (zh) |
CR (1) | CR20120601A (zh) |
EA (1) | EA201291281A1 (zh) |
ES (1) | ES2523572T3 (zh) |
HK (1) | HK1179609A1 (zh) |
IL (1) | IL222602A0 (zh) |
MA (1) | MA34250B1 (zh) |
MX (1) | MX2012013580A (zh) |
PE (1) | PE20130776A1 (zh) |
SG (1) | SG186327A1 (zh) |
TW (1) | TWI412526B (zh) |
WO (1) | WO2011161008A1 (zh) |
ZA (1) | ZA201209089B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014199960A1 (ja) * | 2013-06-10 | 2014-12-18 | 大正製薬株式会社 | グリシントランスポーター阻害物質 |
KR102380870B1 (ko) | 2019-06-19 | 2022-03-31 | 한양대학교 에리카산학협력단 | 퀴놀리지딘 화합물 및 그 제조방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA795318B (en) * | 1978-10-13 | 1980-09-24 | Hoffmann La Roche | Phenyl quinolizidines |
NZ191763A (en) | 1978-10-13 | 1984-05-31 | Hoffmann La Roche | 7-beta-phenyl-quinolidines, intermediates and pharmaceutical compositions |
EP0067565A1 (en) * | 1981-06-16 | 1982-12-22 | Beecham Group Plc | Pharmaceutically active compounds |
EP1326863A2 (en) * | 2000-09-22 | 2003-07-16 | Ortho-McNeil Pharmaceutical, Inc. | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
US6884806B2 (en) * | 2001-10-17 | 2005-04-26 | Bristol-Myers Squibb Company | Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
FR2906251B1 (fr) | 2006-09-22 | 2008-11-07 | Sanofi Aventis Sa | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique |
EP2307378A1 (en) * | 2008-06-18 | 2011-04-13 | Pfizer Limited | Nicotinamide derivatives |
-
2011
- 2011-06-16 US US13/161,534 patent/US8143273B2/en not_active Expired - Fee Related
- 2011-06-17 EA EA201291281A patent/EA201291281A1/ru unknown
- 2011-06-17 SG SG2012091682A patent/SG186327A1/en unknown
- 2011-06-17 ES ES11726146.1T patent/ES2523572T3/es active Active
- 2011-06-17 MX MX2012013580A patent/MX2012013580A/es active IP Right Grant
- 2011-06-17 CN CN201180030484.9A patent/CN102947301B/zh not_active Expired - Fee Related
- 2011-06-17 WO PCT/EP2011/060077 patent/WO2011161008A1/en active Application Filing
- 2011-06-17 BR BR112012030886A patent/BR112012030886A2/pt not_active IP Right Cessation
- 2011-06-17 CA CA2797874A patent/CA2797874C/en not_active Expired - Fee Related
- 2011-06-17 MA MA35397A patent/MA34250B1/fr unknown
- 2011-06-17 PE PE2012002454A patent/PE20130776A1/es not_active Application Discontinuation
- 2011-06-17 AU AU2011269147A patent/AU2011269147A1/en not_active Abandoned
- 2011-06-17 JP JP2013515818A patent/JP5659299B2/ja not_active Expired - Fee Related
- 2011-06-17 EP EP11726146.1A patent/EP2585460B1/en active Active
- 2011-06-17 KR KR1020127032605A patent/KR101431949B1/ko active IP Right Grant
- 2011-06-20 TW TW100121497A patent/TWI412526B/zh not_active IP Right Cessation
- 2011-06-21 AR ARP110102139A patent/AR082766A1/es unknown
-
2012
- 2012-10-10 CO CO12178886A patent/CO6630104A2/es active IP Right Grant
- 2012-10-22 IL IL222602A patent/IL222602A0/en unknown
- 2012-11-28 CR CR20120601A patent/CR20120601A/es unknown
- 2012-11-30 ZA ZA2012/09089A patent/ZA201209089B/en unknown
- 2012-12-17 CL CL2012003553A patent/CL2012003553A1/es unknown
-
2013
- 2013-06-05 HK HK13106614.8A patent/HK1179609A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20130028756A (ko) | 2013-03-19 |
ZA201209089B (en) | 2013-08-28 |
EA201291281A1 (ru) | 2013-06-28 |
MX2012013580A (es) | 2013-01-24 |
AU2011269147A1 (en) | 2012-11-01 |
BR112012030886A2 (pt) | 2016-11-08 |
AR082766A1 (es) | 2013-01-09 |
TWI412526B (zh) | 2013-10-21 |
IL222602A0 (en) | 2012-12-31 |
CN102947301B (zh) | 2015-02-11 |
CA2797874A1 (en) | 2011-12-29 |
EP2585460B1 (en) | 2014-10-01 |
CR20120601A (es) | 2013-01-03 |
WO2011161008A1 (en) | 2011-12-29 |
SG186327A1 (en) | 2013-01-30 |
CN102947301A (zh) | 2013-02-27 |
ES2523572T3 (es) | 2014-11-27 |
KR101431949B1 (ko) | 2014-08-19 |
US20110313165A1 (en) | 2011-12-22 |
CO6630104A2 (es) | 2013-03-01 |
TW201206928A (en) | 2012-02-16 |
EP2585460A1 (en) | 2013-05-01 |
JP5659299B2 (ja) | 2015-01-28 |
JP2013529609A (ja) | 2013-07-22 |
CL2012003553A1 (es) | 2013-03-22 |
CA2797874C (en) | 2018-04-24 |
MA34250B1 (fr) | 2013-05-02 |
PE20130776A1 (es) | 2013-07-03 |
US8143273B2 (en) | 2012-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL222288A0 (en) | Heterocyclic compounds and their uses | |
ZA201301120B (en) | Heterocyclic compound and use thereof | |
HK1198433A1 (zh) | -酰基二肽衍生物及其應用 | |
IL221511A (en) | Arilatriazolones associated with bis aryl and their use | |
HK1182594A1 (zh) | -取代的- -磺酰基- -氟嘧啶酮衍生物 | |
EP2634186A4 (en) | naphthyridine | |
AP4055A (en) | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | |
ZA201208173B (en) | Peptices and their use | |
HK1198646A1 (zh) | 取代的咪唑並噠嗪類化合物及其用途 | |
EP2604597A4 (en) | HETEROCYCLIC COMPOUND AND USE THEREOF | |
HK1202291A1 (zh) | 異喹啉和二氮雜萘衍生物 | |
ZA201303773B (en) | Compounds and their use | |
EP2575453A4 (en) | OLIGO-BENZAMIDE COMPOUNDS AND THEIR USE | |
EP2558094A4 (en) | PYRIDONE DERIVATIVES | |
PT2566849T (pt) | Derivados de 8-hidroxiquinolina | |
GB2490849B (en) | Di-aspirin derivatives | |
HK1174625A1 (zh) | 吡唑並吡啶衍生物 | |
AP2012006419A0 (en) | Aminoquinoline derivatives | |
HK1179609A1 (zh) | 喹嗪烷和吲嗪烷衍生物 | |
HK1184455A1 (zh) | 種喹啉衍生物及其應用 | |
GB201020848D0 (en) | Compounds and their use | |
GB201018028D0 (en) | Compounds and their use | |
GB201017822D0 (en) | Compounds and their use | |
GB201005511D0 (en) | Compounds and their use | |
GB201002337D0 (en) | Compounds and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230615 |